Assessing Cytokinetics (CYTK) Valuation After Recent Share Price Weakness And Aficamten Expectations [Yahoo! Finance]
Cytokinetics, Incorporated (CYTK)
Last cytokinetics, incorporated earnings: 3/3 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.cytokinetics.com/investor-overview
Company Research
Source: Yahoo! Finance
Cytokinetics stock overview Cytokinetics (CYTK) has been drawing attention as investors reassess its late stage pipeline in muscle focused therapies, alongside its current share price of US$62.22 and a mix of short term and longer term total returns. See our latest analysis for Cytokinetics. While the 1 day and 7 day share price returns of a 0.65% decline and an 8.42% decline suggest recent momentum has cooled, the 1 year total shareholder return of 35.26% and 5 year total shareholder return of 216.16% reflect a much stronger longer term picture as investors weigh Cytokinetics' late stage pipeline progress against current risks. If this kind of biotech volatility has your attention, it can be useful to compare with other growth stories in healthcare technology using our screener of 27 healthcare AI stocks as potential idea starters. With Cytokinetics trading at US$62.22 against an average analyst price target of US$91.17 and some recent share price weakness, you have to ask
Show less
Read more
Impact Snapshot
Event Time:
CYTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYTK alerts
High impacting Cytokinetics, Incorporated news events
Weekly update
A roundup of the hottest topics
CYTK
News
- Cytokinetics to Participate in March Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Cytokinetics to Participate in March Investor ConferencesGlobeNewswire
- Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.MarketBeat
- Cytokinetics (CYTK) had its "neutral" rating reaffirmed by Bank of America Corporation.MarketBeat
- Cytokinetics (CYTK) had its price target raised by Needham & Company LLC from $84.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
CYTK
Earnings
- 2/24/26 - Miss
CYTK
Sec Filings
- 3/2/26 - Form 144
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- CYTK's page on the SEC website